This inventor holds 1 USPTO granted patent and 8 published patent applications and 5 EPO patents. Top assignee: Prosidion Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Celebrating Innovation: Lisa Sarah Bertram and Her Contributions to Medicine
Introduction: Lisa Sarah Bertram, based in Oxford, GB, is a prominent inventor recognized for her significant contributions to the field of medicinal chemistry. With a focus on addressing critical health issues, she has developed innovative solutions that hold promise for the treatment of obesity and diabetes.
Latest Patents: Lisa holds a patent for G-protein coupled receptor agonists, which include compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof. This invention, specifically targeting GPR116, presents a groundbreaking approach for managing obesity and diabetes.
Career Highlights: Lisa is currently associated with Prosidion Limited, a company dedicated to advancing treatments in metabolic diseases. Her work is pivotal in the development of novel pharmacological therapies, making her a key figure within the organization.
Collaborations: Throughout her career, Lisa has collaborated with notable professionals, including Matthew Colin Thor Fyfe and Gerard Hugh Thomas. These partnerships have fostered innovation and driven the development of effective therapeutic strategies.
Conclusion: Lisa Sarah Bertram exemplifies the spirit of invention and innovation in the biomedical field. Her groundbreaking patent and impactful collaborations reflect her commitment to improving health outcomes, making her a notable figure in the landscape of modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile